Nature's Sunshine Q2 2022 Earnings Report
Key Takeaways
Nature's Sunshine's net sales were $104.2 million compared to $109.0 million in the same year-ago quarter. GAAP net income was $1.0 million, or $0.03 per diluted common share, compared to $6.8 million, or $0.32 per diluted common share. Adjusted EBITDA was $9.0 million compared to $13.4 million.
Net sales were $104.2 million compared to $109.0 million.
GAAP net income was $1.0 million, or $0.03 per diluted common share, compared to $6.8 million, or $0.32 per diluted common share.
Adjusted EBITDA was $9.0 million compared to $13.4 million.
Revenue was flat on a constant currency basis, driven by continued rapid growth in Asia and mitigated losses in Europe.
Nature's Sunshine
Nature's Sunshine
Nature's Sunshine Revenue by Segment
Nature's Sunshine Revenue by Geographic Location
Forward Guidance
The Company recognizes the volatility and uncertainty of the operating environment and will continue to invest in its five global growth strategies and support its partners around the world.
Positive Outlook
- Continue to invest in our five global growth strategies
- Support our partners around the world
- Strong balance sheet
- Confidence in our long-term vision
- Continued rapid growth in Asia
Challenges Ahead
- Volatility and uncertainty of the operating environment
- Devastating war in Ukraine
- Rampant inflation
- Supply chain pressures
- Lingering impact of COVID-19
Revenue & Expenses
Visualization of income flow from segment revenue to net income